CAT No: CP26224
CAS No: 117106-20-4
Synonyms/Alias: 117106-20-4;Fmoc-N-Me-Thr(tBu)-OH;(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tert-butoxy)butanoicacid;Fmoc-N-methyl-O-t-butyl-L-threonine;N-Fmoc-N-Methyl-O-tert-butyl-L-threonine;PubChem19052;SCHEMBL955882;TMA042;CTK3J1823;MolPort-006-701-288;ZINC2389704;ANW-56031;AKOS015837117;AKOS015908870;AN-7894;RTR-003069;AJ-35606;AK-41291;Fmoc-N-Alpha-Methyl-O-T-Butyl-L-Threonine;TR-003069;FT-0652956;ST24034083;ST51054923;M03390;N-Fmoc-N-Methyl-O-tert-butyl-L-threonine;(2S,3R)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-[(2-methylpropan-2-yl)oxy]butanoic acid;(2S,3R)-3-(TERT-BUTOXY)-2-{(9H-FLUOREN-9-YLMETHOXY)CARBONYLAMINO}BUTANOIC ACID;L-Threonine, O-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-;MFCD02094431;Fmoc-N-Me-L-Thr(tBu)-OH;Fmoc-N-methyl-O-tert-butyl-L-threonine;Fmoc-MeThr(tBu)-OH;Fmoc-N-Alpha-Methyl-O-T-Butyl-L-Threonine;SCHEMBL955882;DTXSID80426643;Fmoc-N-Me-Thr(tBu)-OH, 97%;fmoc-N-me-thr(tbu)-oh, AldrichCPR;AKOS015837117;AKOS015908870;AC-8574;CS-W014461;HY-W013745;DA-73496;DS-13826;Fmoc-Nalpha-Methyl-O-tert-butyl-L-threonine;F12343;M03390;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-O-t-butyl-L-threonine;O-tert-Butyl-N-{[(9H-fluoren-9-yl)methoxy]carbonyl}-N-methyl-L-threonine;(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tert-butoxy)butanoicacid;(2S,3R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-tert-butoxybutanoic acid;N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-N-methyl-L-threonine
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C24H29NO5 |
M.W/Mr. | 411.5 |
Sequence | Three Letter Code:Fmoc-N(Me)Thr(tBu)-OH |
Size | 1 g;5 g; |
InChI | 1S/C24H29NO5/c1-15(30-24(2,3)4)21(22(26)27)25(5)23(28)29-14-20-18-12-8-6-10-16(18)17-11-7-9-13-19(17)20/h6-13,15,20-21H,14H2,1-5H3,(H,26,27)/t15-,21+/m1/s1 |
InChI Key | VIUVLZHFMIFLHU-VFNWGFHPSA-N |
Canonical SMILES | CC(C(C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)OC(C)(C)C |
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com